Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accounts Payables (2016 - 2025)

Phibro Animal Health has reported Accounts Payables over the past 13 years, most recently at $133.3 million for Q4 2025.

  • Quarterly results put Accounts Payables at $133.3 million for Q4 2025, up 34.04% from a year ago — trailing twelve months through Dec 2025 was $133.3 million (up 34.04% YoY), and the annual figure for FY2025 was $138.2 million, up 61.51%.
  • Accounts Payables for Q4 2025 was $133.3 million at Phibro Animal Health, up from $130.6 million in the prior quarter.
  • Over the last five years, Accounts Payables for PAHC hit a ceiling of $138.2 million in Q2 2025 and a floor of $62.8 million in Q1 2021.
  • Median Accounts Payables over the past 5 years was $86.0 million (2023), compared with a mean of $91.7 million.
  • Biggest five-year swings in Accounts Payables: dropped 22.74% in 2023 and later surged 61.51% in 2025.
  • Phibro Animal Health's Accounts Payables stood at $80.7 million in 2021, then fell by 0.22% to $80.5 million in 2022, then increased by 7.36% to $86.4 million in 2023, then rose by 15.09% to $99.4 million in 2024, then surged by 34.04% to $133.3 million in 2025.
  • The last three reported values for Accounts Payables were $133.3 million (Q4 2025), $130.6 million (Q3 2025), and $138.2 million (Q2 2025) per Business Quant data.